Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.3M Buy
49,490
+1,243
+3% +$137K 0.02% 621
2026
Q1
$5.07M Buy
48,247
+268
+0.6% +$31.5K 0.02% 564
2025
Q4
$5.99M Buy
47,979
+4,497
+10% +$536K 0.02% 497
2025
Q3
$5.11M Buy
43,482
+4,176
+11% +$441K 0.02% 555
2025
Q2
$3.61M Sell
39,306
-3,006
-7% -$274K 0.01% 675
2025
Q1
$3.72M Buy
42,312
+1,609
+4% +$158K 0.02% 666
2024
Q4
$3.77M Buy
40,703
+5,628
+16% +$542K 0.02% 654
2024
Q3
$3.25M Sell
35,075
-123
-0.3% -$10.3K 0.01% 725
2024
Q2
$2.64M Buy
35,198
+2,454
+7% +$196K 0.01% 793
2024
Q1
$2.83M Buy
32,744
+12,138
+59% +$928K 0.01% 750
2023
Q4
$1.43M Buy
+20,606
New +$1.24M 0.01% 884

Other funds holding CRH

Pathstone Holdings's CRH Position: Q2 2026 in Review

Pathstone Holdings increased its CRH (CRH) stake by 2.6% in Q2 2026, buying an estimated $137K and bringing the position to 49,490 shares worth $5.3M. The position accounts for 0.02% of the portfolio, ranked #621.

Pathstone Holdings first reported a position in CRH in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.99M in Q4 2025. 1,023 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • Pathstone Holdings held 49,490 shares of CRH worth $5.3M as of Q2 2026.
  • Pathstone Holdings bought 1,243 CRH shares in Q2 2026, an estimated $137K.
  • CRH made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #621 holding.
  • Pathstone Holdings first reported a position in CRH in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's CRH position peaked at $5.99M in Q4 2025.
  • 1,023 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.